[1]Ripatti S, Tikkanen E, Orho-Melander M, et al. A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses[J]. Lancet, 2010, 376: 1393-1400. [2]Kang J, Kim H, Mun D, et al. Co-delivery of curcumin and miRNA-144-3p using heart-targeted extracellular vesicles enhances the therapeutic efficacy for myocardial infarction[J]. J Control Release, 2021, 331: 62-73. [3]Lin Y, Ko C, Liu S, et al. miR-144-3p ameliorates the progression of osteoarthritis by targeting IL-1β: Potential therapeutic implications[J]. J Cell Physiol, 2021, 236: 6988-7000. [4]Rodrigo-Muñoz J, Gil-Martínez M, Lorente-Sorolla C, et al. miR-144-3p is a biomarker related to severe corticosteroid-dependent asthma[J]. Front Immunol, 2022, 13: 858722-858732. [5]Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways[J]. Nat Rev Mol Cell Biol, 2019, 20: 5-20. [6]陶臻博,张泽波,何昕,等.微小RNA与高血压关系研究进展[J].生命科学,2021,33:869-875. [7]Poller W, Dimmeler S, Heymans S, et al. Non-coding RNAs in cardiovascular diseases: diagnostic and therape-utic perspectives[J]. Eur Heart J, 2018, 39: 2704-2716. [8]Chang J, Nicolas E, Marks D, et al. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1[J]. RNA Biol, 2004, 1: 106-113. [9]Tian L, Cai D, Zhuang D, et al. miR-96-5p regulates proliferation, migration, and apoptosis of vascular smooth muscle cell induced by angiotensin Ⅱ via targeting NFAT5[J]. J Vasc Res, 2020, 57: 86-96. [10]张传西,张宇,郭莎莎,等.血清miR-181b和miR-27a表达与颈动脉粥样硬化程度相关[J].基础医学与临床,2021,41: 1133-1138. [11]郭婧,李亚洁,牟寒霜.LncRNA FGD5-AS1靶向miR-106a-5p减轻ox-LDL诱导的HUVECs损伤[J].基础医学与临床,2022,42: 768-775. [12]Li S, Shao J, Lou G, et al. miR-144-3p-mediated dysregulation of EIF4G2 contributes to the development of hepatocellular carcinoma through the ERK pathway[J]. J Exp Clin Cancer Res, 2021, 40: 53-67. [13]Wang P, Yang Z, Ye T, et al. lncTUG1/miR-144-3p affect the radiosensitivity of esophageal squamous cell carcinoma by competitively regulating c-MET[J]. J Exp Clin Cancer Res, 2020, 3: 7-19. [14]Matsushita R, Seki N, Chiyomaru T, et al. Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer[J]. Br J Cancer, 2015, 113: 282-289. [15]Sun H, Ren X, Xiong X, et al. NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension[J]. Cell Death Dis, 2017, 8: e3074-e3086. |